From sciencedaily.com
Source: Zhejiang University
Melatonin is now widely used to help children sleep, but scientists say the enthusiasm may be getting ahead of the evidence. A major review found clear benefits for children with conditions like autism and ADHD, yet far less data exists for typical childhood insomnia. Researchers also warn about mislabelled supplement doses and rising accidental ingestions among young kids. Experts say melatonin should be used carefully and only alongside proven behavioural sleep strategies.
Melatonin has quickly become one of the most widely used sleep aids for children around the world. Its popularity is largely driven by the belief that it is a natural and easily accessible solution for insomnia. However, new research suggests that its rapid growth in use has moved faster than the scientific understanding of how safe and effective it truly is for children over the long term.
Melatonin appears to provide clear benefits for sleep difficulties in children with neurodevelopmental conditions. Yet for children without these conditions, strong evidence remains limited. Researchers are also concerned about inconsistent dosing in over the counter products, use without medical supervision, and a growing number of accidental ingestions. Taken together, these concerns point to the need for more caution, stronger regulation, and clearer evidence based guidance when melatonin is used to address sleep problems in children.
Why Families Are Turning to Melatonin
Sleep difficulties are becoming increasingly common among children and teenagers. Poor sleep can influence emotional regulation, cognitive development, and overall health. As parents look for quick and convenient solutions, melatonin supplements have become widely used because they are easy to obtain, often come in child friendly forms, and are widely perceived as a safe alternative to prescription medications.
Despite that perception, melatonin is actually a hormone that affects more than just sleep cycles. It plays roles in regulating the immune system, metabolism, and reproductive processes. Research on melatonin use in children is still uneven. Many studies only examine short term outcomes or focus on specific clinical populations. Because of these limitations, researchers say there is an urgent need to carefully evaluate the safety, effectiveness, and appropriate use of melatonin in paediatric care.
Review Examines Global Melatonin Use in Kids
A narrative review published in World Journal of Paediatrics, by researchers at Boston Children's Hospital explored the rapid rise of melatonin use among children and adolescents worldwide. The review analysed clinical evidence related to melatonin's effectiveness, safety profile, and patterns of real world use.
Researchers found a clear mismatch between the widespread use of melatonin and the limited amount of long term scientific data available. The review also highlighted concerns about inappropriate use, inconsistent product quality, and the lack of strong regulatory oversight for sleep supplements marketed to children.
Evidence Shows Benefits for Some Children
According to the review, melatonin use among children has increased sharply over the past decade. This growth is especially noticeable in countries where the supplement is sold over the counter.
Strong clinical evidence supports melatonin's short term benefits for children with neurodevelopmental disorders such as autism and attention deficit hyperactivity disorder. In these cases, melatonin can help children fall asleep more quickly, extend total sleep time, and improve overall quality of life for caregivers.
Limited Data for Typically Developing Children
The situation is less clear for children who do not have underlying developmental conditions. Research in this group is limited and often inconsistent. Most randomized clinical trials have been short in duration and focus primarily on older children or teenagers. As a result, researchers cannot draw strong conclusions about younger children, even though melatonin use in that age group is becoming more common.
Long term safety data are especially limited. Scientists still have unanswered questions about whether melatonin could influence puberty, immune function, metabolism, or neurological development when used over extended periods.
Safety Concerns About Melatonin Products
The review also highlights several safety issues that may occur outside controlled clinical environments. Testing of commercial melatonin supplements has revealed major differences between labelled doses and the actual amount of melatonin contained in some products. In some cases, supplements contained several times the stated dose or unexpected compounds such as serotonin.
Data from paediatric poison control centres also show a sharp increase in accidental melatonin ingestions among children. Young children appear particularly vulnerable, often due to gummy formulations that resemble candy and improper storage at home. These findings suggest that the risks associated with real world melatonin use may be higher than previously assumed.
Experts Urge Careful and Limited Use
Researchers caution that melatonin should not be treated as a quick fix for childhood sleep problems. Although it can be useful in certain carefully selected situations, particularly when guided by a healthcare professional, it should not replace thorough sleep assessments or behavioural interventions.
The review stresses that both clinicians and caregivers should view melatonin as a biologically active hormone rather than a harmless supplement. Without stronger evidence and better regulation, routine or unsupervised use could expose children to unnecessary risks while drawing attention away from proven non pharmacological strategies that support healthy sleep.
Behavioural Sleep Strategies Remain First Line Treatment
The findings have important implications for paediatric medicine, public health policy, and caregiver education. Behavioural approaches to sleep should remain the primary treatment for childhood insomnia. These strategies include maintaining consistent bedtime routines, limiting screen exposure before bed, and setting age appropriate sleep expectations.
If melatonin is used, the review recommends starting with the lowest effective dose, limiting the duration of treatment, and using it only under medical supervision. Researchers also emphasize the need for stronger oversight of melatonin products designed for children, clearer labelling standards, and more long term clinical research. These steps could help ensure that children receive safe, effective, and evidence based support for healthy sleep.
https://www.sciencedaily.com/releases/2026/03/260315004407.htm
